StonvexLoading…
StonvexStonvexStonvexCore line items from GBLI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $450.10M | $441.19M | $528.13M | $628.53M |
Operating Income | $33.30M | $54.96M | $32.98M | $1.97M |
Net Income | $25.33M | $43.24M | $25.43M | $-850.00K |
EPS (Diluted) | $1.75 | $3.12 | $1.83 | $-0.09 |
Total Assets | $1.72B | $1.73B | $1.73B | $1.80B |
Total Liabilities | $1.01B | $1.04B | $1.08B | $1.17B |
Cash & Equivalents | $65.54M | $17.01M | $38.04M | $38.85M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 14.26M | 13.71M | 13.67M | 14.48M |